Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- Check2 days agoChange DetectedA government funding status notice has been added and the revision is updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check10 days agoChange DetectedGlossary is now shown by default. Added metadata fields include Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed are the previously displayed (Estimated) indicators and Revision: v3.3.4.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing v3.3.3, a minor update with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations section updated with new site listings across multiple states and Ontario. Page revision updated to v3.3.3.SummaryDifference2%

- Check53 days agoChange DetectedThe update timestamp label changes from 'Last Update Posted' to 'Last Update Posted (Estimated)'. This is a minor textual adjustment to the update information on the study details page.SummaryDifference0.0%

- Check60 days agoChange DetectedNew 'Last Update Posted' dates were added (2025-12-08 and 2025-11-22), and the previously listed 'Last Update Posted (Estimated)' entries (2025-11-06 and 2025-11-19) were removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.